Onconova Therapeutics, Inc. (ONTX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.61, down from yesterday’s close by -14.31%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Onconova Therapeutics, Inc. (ONTX) currently trades with a market capitalization of $38.70 Million. That value represents a market adjusting for revenues that have been growing by 168.57 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$23.27 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.08 on a per share basis this quarter. Perhaps, that suggests something about why 7.29% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how ONTX has been acting. Looking at the stock’s movement on the chart, Onconova Therapeutics, Inc. recorded a 52-week high of $2.83. It is now trading 2.22% off that level. The stock is trading $0.53 its 50-day moving average by -0.08%. The stock carved out a 52-week low down at $0.33.
In recent action, Onconova Therapeutics, Inc. (ONTX) has made a move of +63.98% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.04, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange.